offline
Bristol-Myers Squibb (BMY) Tops Q1 Earnings and Revenue Estimates
Bristol-Myers Squibb (BMY) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 16.22%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.30 per share when it actually produced earnings of $1.22, delivering a surprise of -6.15%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Bristol-Myers, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $10.78 billion for the quarter ended March 2020, surpassing the Zacks Consensus Estimate by 8.62%. This compares to year-ago revenues of $5.92 billion.
...
https://finance.yahoo.com/news/bristol-m...12208.html
![[Bild: BMYc1dl0725.png]](https://finviz.com/publish/050820/BMYc1dl0725.png)
Bristol-Myers Squibb (BMY) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 16.22%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.30 per share when it actually produced earnings of $1.22, delivering a surprise of -6.15%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Bristol-Myers, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $10.78 billion for the quarter ended March 2020, surpassing the Zacks Consensus Estimate by 8.62%. This compares to year-ago revenues of $5.92 billion.
...
https://finance.yahoo.com/news/bristol-m...12208.html
__________________
